Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 221

    Zydus Cadila gets USFDA nod for Desoximetasone cream

    Zydus Cadila gets USFDA nod for Desoximetasone cream

    Medical Dialogues Bureau2 Oct 2018 10:20 AM IST
    New Delhi: Drug firm Zydus Cadila has recently announced that received a final nod from the US health regulator to market generic Desoximetasone cream...
    Apollo Hospitals gets shareholders approval to issue Rs 5-billion NCDs

    Apollo Hospitals gets shareholders' approval to issue Rs 5-billion NCDs

    Medical Dialogues Bureau2 Oct 2018 9:20 AM IST
    New Delhi: Apollo Hospitals, India's largest hospital chain, has recently informed stock exchanges that its shareholders had approved its plan to...
    Sanofi, Regeneron skin cancer drug gets FDA nod

    Sanofi, Regeneron skin cancer drug gets FDA nod

    Medical Dialogues Bureau2 Oct 2018 9:00 AM IST
    Sanofi Genzyme, the company’s speciality care unit and Regeneron will market Libtayo jointly in the United States.Banglore: Sanofi SA has recently...
    Diagnostics firm Metropolis Healthcare files IPO draft papers with SEBI

    Diagnostics firm Metropolis Healthcare files IPO draft papers with SEBI

    Medical Dialogues Bureau1 Oct 2018 10:45 AM IST
    New Delhi: Diagnostics company Metropolis Healthcare has filed its draft papers with market regulator Sebi for its initial public offering (IPO).The...
    Sterling Biotech case: Supplementary charge sheet filed

    Sterling Biotech case: Supplementary charge sheet filed

    Medical Dialogues Bureau1 Oct 2018 10:20 AM IST
    New Delhi: The Enforcement Directorate (ED) on Saturday filed a supplementary charge sheet against a man arrested for allegedly sending Rs 25 lakh to...
    Insmed treatment-resistant lung disease drug gets FDA approval

    Insmed treatment-resistant lung disease drug gets FDA approval

    Medical Dialogues Bureau1 Oct 2018 9:45 AM IST
    New Delhi: The U.S. Food and Drug Administration has approved Insmed Inc's lead drug to treat a rare, chronic lung disease, making it the first...
    FDA halts imports from Chinas Huahai over valsartan drug Recall

    FDA halts imports from China's Huahai over valsartan drug Recall

    Medical Dialogues Bureau1 Oct 2018 9:15 AM IST
    The FDA and the European Medicines Agency announced that another known carcinogen called N-Nitrosodiethylamine, or NDEA, had also been found in...
    AstraZeneca donation of Rs 10 Lakh to CMDRF

    AstraZeneca donation of Rs 10 Lakh to CMDRF

    Medical Dialogues Bureau30 Sept 2018 11:06 AM IST
    Thirvanthpuram: In the wake of recent floods witnessed by Kerala, employees of AstraZeneca Pharma India Limited has donated Rs 10 lakh for Chief...
    Max Bupa Health app enables customers to book cashless OPD instantly

    Max Bupa Health app enables customers to book cashless OPD instantly

    Medical Dialogues Bureau30 Sept 2018 10:57 AM IST
    Customers’ fitness data and health score from Max Bupa Health Coach mobile app are integrated real-time within this app. They can also link their...
    USFDA Approves Libtayo injection for treating metastatic cutaneous squamous cell carcinoma

    USFDA Approves Libtayo injection for treating metastatic cutaneous squamous cell carcinoma

    Medical Dialogues Bureau30 Sept 2018 10:03 AM IST
    New Delhi: The U.S. Food and Drug Administration has approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients...
    Novartis strikes deal with Chinese firm to make Kymriah

    Novartis strikes deal with Chinese firm to make Kymriah

    Medical Dialogues Bureau30 Sept 2018 9:15 AM IST
    Novartis recently announced production pacts in France, Germany and Switzerland, where it is building its own Kymriah factory.ZURICH: Novartis has...
    ED to File Charge Sheet Against Sterling Biotech in Bank Loan Fraud Case of Over Rs 5000 Crore

    ED to File Charge Sheet Against Sterling Biotech in Bank Loan Fraud Case of Over Rs 5000 Crore

    Medical Dialogues Bureau29 Sept 2018 5:00 PM IST
    New Delhi: A Delhi court has directed the ED to file within a week its charge sheet against a man arrested in over Rs 5,000 crore-bank loan fraud case...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok